UPDATE – Clinician FAQs and guidance on COVID-19 vaccine for patients receiving SACT – Version 4.0

Note that version 4.0 of ‘Clinician FAQs and guidance on COVID-19 vaccine for patients receiving SACT’ is now available on the UKCB website here: https://www.ukchemotherapyboard.org/publications.

Updated for this version:

Latest News

By BOPA on 14th March 2024

Health Innovation Sprint Events

Health Tech Enterprises is a hub that supports the trust to commercialise our innovations. They are running a sprint challenge for potential innovators and this will give them access to…

Read article
By BOPA E&T on 12th March 2024

LCC Reviewers Required

The ‘Let’s Communicate Cancer’ working group have a great opportunity for pharmacists to become involved in the review of the ‘Let’s communicate cancer’ training modules.   ‘Let’s communicate cancer’ is…

Read article
By BOPA Research Subcommittee on 27th February 2024

Bispecific Antibodies Survey

We are embarking on a national project to help implement bispecific antibodies as a treatment for multiple myeloma accessed through clinical trials, named patient schemes or routine care if NICE…

Read article
By BOPA Committee on 26th February 2024

Important updates on the BOPA digital SACT Verification Passport

Since the launch There has been an overwhelming uptake with most UK organisations registering for Passport use. There is a specific email inbox manned by the verification passport volunteers, to…

Read article